Sun Pharmaceutical Industries has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration (FDA). CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye)
0 thoughts on “Sun Pharma gets USFDA approval for CEQU 009for topical ophthalmic use”